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Diabetic patients who may require surgery can present a challenge in the perioperative 
arena.  Maintaining glycemic and metabolic control can prove to be difficult, especially 
in the type I diabetic who utilizes an insulin pump.  Special attention to how these 
patients are monitored, as well as criteria for maintaining those on insulin pumps and 
appropriate patient selection, presents its own set of challenges.  This paper will examine 
one such individual who will be undergoing a total knee replacement (TKR) who has 
been managed with an insulin pump for the past 33 years. Current guidelines and 
practices as it pertains to this type of patient will be examined and evaluated. With the 
growing number of those individuals who are on continuous insulin therapy, along with 
the increasing number of operative procedures, we hope to gain insight as to how to care 
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                                                              Background 
At least 1.4 million people are diagnosed with diabetes each year, and that 
number continues to increase (American Diabetes Association, 2014).  According to the 
Centers for Disease Control (CDC), there are 29.1 million people living with diabetes or 
9.3% of the United States population (CDC, 2014).  From the year 1980 to 2014, the 
number of adults in the United States, ages 18-79, with newly diagnosed diabetes more 
than tripled from 493,000 to over 1.4 million in 2014 (CDC, 2015).  While it is not 
known specifically how many are utilizing insulin pump therapy, it is estimated that it 
may be between 20-30% of people in the United States (Partridge, Perkins, Mathieu, 
Nicholls, & Adeniji, 2016). Of those with Type I diabetes, insulin pump therapy is the 
most effective method of treatment for diabetic control.  
The use of continuous subcutaneous insulin infusion, or CSII, has been in 
existence for more than 20 years and its usage has increased in the management of the 
patient with type I diabetes. Insulin pumps work by mimicking normal physiology of 
insulin or basal-bolus regimen.  Because a Type I diabetic is void of insulin, the insulin 
pump ensures that they are receiving small doses of short acting insulin continuously 
over a 24-hour period.  An advantage to using the pump is the amount of insulin given is 
more accurate and precise.  This leads to improving HgA1C levels as well as fewer 
swings in blood sugars.  These fewer swings in glucose levels are due to the elimination 
of long-acting insulins.  The pump also provides the individual with more flexibility with 
scheduling of meals and can prevent or reduce sudden drops in blood glucose. The 
disadvantages to the pump are increased risk of weight gain, the risk of diabetic 
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ketoacidosis, should the catheter come out, and the nuisance of being attached to a pump 
on a continual basis (American Diabetes Association, 2015). 
Managing glycemic control and metabolic control can be difficult in an individual 
with type I diabetes. It is well established that stress such as surgery and anesthesia can 
invoke a neuroendocrine response leading to the release of counter regulatory hormones.  
This can lead to peripheral insulin resistance, increased hepatic glucose production, 
impaired insulin secretion, potential hyperglycemia and in extreme circumstances, 
ketosis.  In addition to this counter-regulatory hormone excess, fasting and volume 
depletion can contribute to metabolic decompensation.  This response is of course 
dependent on the complexity of the surgical procedure and whether or not there exist any 
surgical or postsurgical complications.  Likewise, having diabetes, despite tight control 
prior to hospitalization, can pose adverse surgical outcomes.  Hyperglycemia can inhibit 
host defense mechanisms, which can lead to infection, impaired wound healing, as well 
as cardiac and renal complications.  Examining what policies and procedures exist, along 
with managing blood sugars during surgery and criteria for proper patient selection will 
be examined in the literature review. 
 
  Case Report 
Patient JB is a 56-year-old Caucasian male who presents to the clinic for a pre-op 
physical prior to having a right TKR, which is scheduled in the next 30 days.  He reports 
that he has always had knee problems due to arthritis and has just completed a left TKR 
this previous December.  He states that the surgery and rehab went well and was only 
hospitalized for one day.  His only problem during surgery was nausea associated with 
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the anesthesia but otherwise he tolerated it well.  He currently has pain to the right knee, 
which he scores at a 5-6 on a 1-10 scale.  The pain does get as low as a 4 and as high as a 
10.  He has been taking Ibuprofen 350mg tabs, utilizing 6-8 tabs/day.  He has tried ice 
packs, but this has not alleviated the pain. 
The patient’s past medical history is significant for hypertension, hyperlipidemia, 
and type I diabetes since the age of 23.  He is currently on Losartan 10mg daily, Novolog 
insulin pump with usual dosage of about 70U/day, Simvastatin 80 mg daily, Aspirin 81 
mg daily and a multivitamin.  He has no known food or drug allergies.  He currently is 
employed full-time as a construction worker and smokes 1 pack of cigarettes per week 
with a 30-pack year history. Alcohol intake is approximately 1-2 drinks per night.  He has 
managed his diabetes well with carbohydrate counting and states that he has a healthy 
diet and eating plan. 
On review of systems, HEENT: denies any visual changes and does receive 
annual eye exams.  He reports that he is hard of hearing to both ears but currently does 
not wear hearing aids. Cardiovascular: denies chest pain or palpitations. Respiratory: 
denies SOB, or cough. Gastrointestinal: denies GI complaints such as nausea, diarrhea or 
constipation.  GU: denies dysuria, difficulty with starting his stream or polyuria. 
Neurological: denies peripheral neuropathy. Endocrine: denies polyuria and polydipsia.  
Again, patient has an implanted insulin pump and controls his blood sugars and insulin 
dosing using carbohydrate counting.  States he keeps his blood sugars between 100-160. 
On physical exam, his blood pressure is 158/94, heart rate 76, resp 20, temp 98.8. 
Labs and diagnostics ordered during this visit included a CBC, CMP, HgA1C and EKG. 
Lab work revealed HgA1C of 6.0, CBC revealed mild iron deficiency anemia with RBC 
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of 3.0, Hct: 34.5, Hgb: 12.0,  MCV: 90.7. CMP was within normal limits. The EKG 
showed normal sinus rhythm. A CXR was deferred since it was done in December prior 
to the last surgery.  HEENT exam was negative.  Cardiovascular exam revealed regular 
heart rate and rhythm without gallops or murmurs.  Pedal pulses were noted to bilateral 
feet.  Respiratory exam was without significant findings. Abdomen was soft and 
nontender and insulin pump was noted to the right lower quadrant.  Skin was warm, dry 
and well pigmented without any open ulcers or lesions.   
Assessment and Plan: Reviewed the preoperative labs with the patient.  Instructed 
him on taking an Iron supplement daily and reviewed that his anemia was probably due 
to blood loss from his previous surgery.  Hypertension was also addressed with 
instructions to continue to monitor blood pressure at home.  JB states he does have a 
blood pressure cuff and that his pressure typically runs in the 130’s/80’s.  Discussed that 
the current guidelines for blood pressure management for his age is no greater than 
140/90.  JB verbalized understanding of the instructions.  Reviewed that the HgbA1C 
was under good control for his surgery.  Patient did not reveal the plan with regards to his 
insulin pump and whether or not he would continue on the pump or be transitioned to 
intravenous insulin. 
Literature Review 
The management of this patient’s diabetes, which included an insulin pump, in the 
perioperative setting sets the stage for this literature review.  A literature search was 
conducted to evaluate the current recommendations and guidelines.  Utilizing the 
University of North Dakota Harley French Library website, a systematic search of 
literature was conducted.  The databases utilized were CINAHL and PubMed with key 
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word search terms of Insulin Pump, Type 1 Diabetes, and Perioperative.  The search 
resulted in a total of 12 articles.  After reviewing the articles and eliminating those that 
were published greater than eight years ago and those that were not focused on the 
perioperative setting exclusively, there were 10 articles that were relevant to this case.  
There were noted to be key elements that were consistent amongst all 10 articles. 
Need for Policy/Procedural Guidelines 
 Insulin pumps are becoming more widely used and with this technology, it 
becomes necessary for current prescribers and future prescribers to have treatment and 
procedure protocols in place.  This becomes even more vital when a patient will be 
undergoing surgery.  The Society for Ambulatory Anesthesia (SAMBA, 2010) first 
addressed this concern in a consensus statement in 2010.  It was prompted by a common 
dilemma in the ambulatory setting due to the number of patients with an implanted pump 
that required surgery.  Some anesthesiologist were hesitant about managing such a 
patient, however, these patients were found to be typically the most knowledgeable, 
motivated and involved in their care and thus, the easiest to manage.  The consensus 
statement did state some guidelines for management.  Their recommendations were for 
basal rate dosage to be that of a “sick day” or “sleep” rate.  It was also suggested that 
intraoperative glucose levels should be maintained less than 180mg/dl with blood glucose 
monitoring occurring every 1-2 hours. However, these recommendations were based 
solely on a literature review, which they stated was sparse and of limited quality.  
 In a retrospective study conducted by Corney et al. (2012), they evaluated both 
Type 1 and Type 2 diabetics who utilized pumps during their surgical procedures.  In 
order to implement the study they first reviewed the recommendations from the American 
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Diabetes Association, as well as the American College of Clinical Endocrinologists to 
establish their policy and procedure guidelines.  One component of the guidelines was the 
implementation of staff and practitioner education. Their success was attributed to 
adequate training and provision of resources.  They also defined what population would 
be most appropriate to participate and how those patients would also be monitored.  They 
concluded that insulin pump therapy during surgery is a safe option, however, it is critical 
that healthcare professionals in this field be competent to manage such patients.  
Likewise, in a study conducted by Boyle et al. (2012), they evaluated outcomes of care 
after implementation of an institutional policy.  When developing their policies, they 
broke them down into four phases: preadmission, preoperative, intraoperative and post 
anesthesia recovery.  A preadmission nurse was to notify endocrinology about the 
upcoming case at least 24 hours before the procedure.  Patient and provider reviewed 
pump settings as well as instructing the patient to bring supplies in case of 
hospitalization.  Specifics of documentation during the procedure were also listed.  This 
included pump connection, infusion of the pump, and location of insertion site.  Blood 
sugars were also monitored in all three phases with intraoperative monitoring occurring 
every hour.  An inpatient diabetes management team was also involved in the post 
anesthesia care unit to assist with that patient’s transition should they be admitted to the 
hospital.   Their findings suggested that insulin pump technology could be safely used in 
this setting.  Utilizing a multidisciplinary team was monumental in developing guidelines 
and successful compliance with necessary procedures.  
 Estimating risk and safety standards is an important component when developing 
policy and procedures.  Important factors to consider are the length of the surgery, time 
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of day that the surgery is performed, with preference placed in the early morning, and the 
individual patient risk factors.  In an article published by Dhinsa, Khan, and Puri (2010) it 
was suggested that utilizing resources such as the World Health Organization’s Surgical 
Safety Checklist, which has been rolled out nationwide, was a good starting point.  The 
checklist was initiated in 2007 in an effort to decrease the number of surgical deaths and 
address safety concerns.  It is a way to ensure that the surgical team consistently follows 
vital safety steps in order to minimize the most common and avoidable risks.  This tool, 
which continues to be in use today, can serve as the framework for developing hospital 
policies and guidelines by addressing safety points from the perioperative period through 
the postoperative period. 
 Clinical practice guidelines have an important role in delivering quality patient 
care.  It is vital to evaluate what the current standards are and how these affect outcomes.  
Mathioudakis & Golden (2015) addressed elements of quality improvement by reviewing 
clinical practice guidelines.  The organizations that were reviewed were the Endocrine 
Society, American College of Physicians, the American Diabetes Association and the 
Society for Ambulatory Anesthesia.  After careful examination, they found that there was 
significant variability amongst agencies. Variability ranged from glucose management, to 
identifying patient population, to when to transition a patient from an insulin pump to 
intravenous insulin.  They also noted that these differences and contraindications in the 
guidelines are likely to create variable practices, which may have implications on patient 
outcomes.  They identified that there needs to be more concrete detail about care 
protocols as well as decision support.   
Intraoperative Glucose Management 
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 The management of the patient with diabetes in the surgical setting requires a 
customized approach for each individual.  It is important to take note of their blood 
glucose control and how well they have been managed prior to surgery.  It is also 
necessary to examine their HgA1C, as well as cardiac and renal function.  Different types 
of anesthesia may also affect glucose homeostasis during surgery.   Minor changes in 
blood glucose during surgery are to be expected and are however, not an indication to 
stop the insulin pump.   
 In an article published by Vann (2009), a review of the impact of glucose control 
as well as the effects of hyper/hypoglycemia and fluctuations of blood glucose were 
examined in order to strategize how to manage blood sugars during surgery.  They found 
that despite the large numbers of diabetic surgical patients, there was very limited data on 
monitoring glucose control during routine ambulatory surgery.  It was also found that 
glucose control with an insulin pump infusion was superior to insulin boluses in 
maintaining a stabilized glucose.  Management of the diabetic patient during surgery 
needs to be a step-wise approach in order to minimize the fluctuations of hypo and 
hyperglycemia.  First step is to assess the patient’s diabetic medications and usual 
glucose control.  The next step is on the day of surgery the patient should have their 
blood sugars checked every 1-2 hours.  Anesthetic management should aim at a stress-
free environment for the patient, which should include the type of anesthetic, pain 
management and control of nausea and vomiting.   They concluded that anesthesiologists, 
especially in the ambulatory setting, are able to provide the ideal environment for the 
patient with diabetes and have the greatest impact on blood sugar management. 
INSULIN PUMP THERAPY 
 
12 
 Data on the management of blood sugars during the perioperative period is 
limited with much of this information being underreported. A multidisciplinary work 
group reviewed current information regarding the documentation of blood glucoses and 
the use of insulin pumps in a case report by Boyle et al. (2012).  They mention that 
although continuous insulin pumps have been used in surgery, the experience of 
practitioners and staff has been underreported and therefore a comprehensive set of 
recommendations has not yet been developed.  They analyzed 50 surgical cases from the 
year 2006-2010 who were on pump therapy during surgery and noted a wide variation on 
how they were managed.  Documentation of the status of the pump was unclear and 
inconsistent and glucose monitoring only occurred in 60% of the cases despite anesthesia 
time of nearly three hours.  Recognizing the need for standardization, the group did 
develop procedural guidelines for monitoring.  Blood glucose levels need to be checked 
in the preoperative phase and both anesthesia and the surgical team should be notified if 
there is a critical value.  Blood glucose levels are then checked hourly during the surgery 
and corrective doses of insulin are given at the direction of the anesthesiologist.  Post 
anesthesia blood glucose is checked in the recovery room and hourly if applicable.  They 
also developed a sample preoperative insulin pump checklist to ensure that 
documentation was happening from preop to post anesthesia.  In an article published by 
Ferrari (2008), it was found that rapid acting insulin analogues have enabled more precise 
glucose control by way of constant infusion.  Insulin pumps, which utilize rapid acting 
insulin, most closely simulate the normal physiologic insulin delivery and therefore 
reduce the episodes of hypo and hyperglycemic events.  They mention that now with the 
emergence of “smart pumps”, which can be programmed to deliver corrected doses of 
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insulin, there will be better control over blood glucose levels in which fluctuations during 
surgery may be uncertain. 
Proper Patient Selection 
 Just as important as having set protocols and guidelines in place to direct care, so 
is defining which patient would be most appropriate when deciding on keeping the CSII 
or utilizing intravenous insulin.  In a commentary in the American Journal of Medicine 
(2015), Bhatt & Reynolds note that although insulin pump users are competent in self-
care as outpatients, it is inappropriate to expect them to respond to the rapidly changing 
insulin requirements that may occur when they are experiencing an acute illness or a 
procedure.  Such factors such as sedation with pain medication and even altered mental 
status can affect and compromise their self-care skills.  This is an important consideration 
when evaluating a patient preoperatively to determine if continued pump use is safe.  
Discussion with the patient is important because many are fearful of relinquishing their 
diabetes control to hospital staff especially if they have limited knowledge of that 
individual’s unique insulin needs.   Contrary to this, many staff have limited experiences 
with insulin pumps and due to the multiple types that may exist, this may also prove to be 
a challenge.  
 Looking at involving a diabetes inpatient specialist and a multi-disciplinary 
approach early on may help minimize some of these concerns.  In an article by Dhatariya 
et al (2012), a clinical pathway was designed for those having elective surgery and CSII.  
This process started with the primary care provider.  Ensuring that adequate HgA1C with 
a recommendation of no higher than 8.5% was a starting point.  For those patients who 
did not have adequate control, a referral to the diabetes specialist team was made.  Other 
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factors taken into consideration were other co-morbidities and how engaged and involved 
the patient was in their care.  The team approach carried through to the recovery phase as 
well.  There were specific instructions and guidelines for staff to follow.   Inpatient 
education by the diabetes specialist team to both patient and staff was a key to the 
success.  This also led to decreased length of stay. 
 As previously mentioned, an important component to patient selection for CSII is 
the ability of the hospital, including providers and staff, to care for this type of patient.  
Before even considering the continuation of this therapy, it is important to ensure that 
education, protocols and involvement of the diabetes team occurs.  It is also important to 
note that insulin pump therapy is not considered appropriate for those with visual or 
cognitive impairments and loss of manual dexterity.  Partridge et al (2016) state that early 
involvement with the diabetes team allows for a definitive management plan to be 
established prior to surgery and will also inform hospital staff as to the competency of the 
patient in regards to their ability to manage the pump.  This being said, it should be 
assumed that during the hospitalization period, the patient (or parent/guardian) will take 
responsibility of the pump during the stay.  The exception to this would be during the 
period of surgery when other hospital staff would take on this obligation.  It is important 
to establish this understanding with the patient prior to signing consent.  They also add 
that for major surgery or emergent surgery, insulin pump therapy is not appropriate and 
pump discontinuation should be advocated.  In these cases, IV insulin should be initiated.   
 With insulin pump therapy becoming an increasingly used modality in the care 
and management of the Type 1 diabetic and the emergence of use in the management of 
Type 2 diabetes, it is becoming increasingly important for healthcare professionals to 
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become familiar with this treatment modality.  Due to the many complications associated 
with diabetes, the need for surgery becomes more and more necessary.  How the care of 
these patients is addressed then becomes the issue. Key factors to be aware of when 
considering whether or not to have a patient continue on CSII during surgery are the 
following: 
• There needs to be facility policies and guidelines in place to direct staff. 
• There still exists much needed research to establish standardized clinical 
guidelines as practice has been based only on recommendations, provider comfort 
level, and literature review. 
• Staff education, to include providers and nursing, both in the perioperative setting 
and the inpatient setting is critical  
• Criteria needs to be determined in order to establish which patients are most 
appropriate to continue on CSII.  This may include not only patient’s ability to 
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